| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10537520 | APOTEX | Stable liquid formulations of melphalan |
Jun, 2036
(12 years from now) | |
Melphalan Hydrochloride is owned by Apotex.
Melphalan Hydrochloride contains Melphalan Hydrochloride.
Melphalan Hydrochloride has a total of 1 drug patent out of which 0 drug patents have expired.
Melphalan Hydrochloride was authorised for market use on 18 August, 2023.
Melphalan Hydrochloride is available in solution;intravenous dosage forms.
The generics of Melphalan Hydrochloride are possible to be released after 29 June, 2036.
Drugs and Companies using
MELPHALAN HYDROCHLORIDE ingredient
Market Authorisation Date:
18 August, 2023Treatment:
NADosage:
SOLUTION;INTRAVENOUS
More Information on Dosage
MELPHALAN HYDROCHLORIDE family patents
